Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs.
Meta-analysis of association between Helicobacter pylori infection and multiple sclerosis.
Psychological and Neurobehavioral Disorders in MSA Health-Oriented, Rehabilitative Perspective.
Assessment of the effect of cigarette smoking on regional brain volumes and lesion load in patients with clinically isolated syndrome.
Prospects of Cinnamon in Multiple Sclerosis.
CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17.
Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis.
Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index.
Risk factors of early onset of MS in women in reproductive age period: survival analysis approach.
Multiple sclerosis and neurofibromatosis type 1: report of seven patients from Iran.
Transverse myelitis and bilateral optic neuritis in a patient with systemic lupus erythematosus.
[Need for creating Polish registry of multiple sclerosis patients].
Botulinum toxin type A in cerebellar tremor caused by multiple sclerosis.
Anti-JC Virus Antibody Prevalence in Canadian MS Patients.
Neuropathology of JC virus infection in progressive multifocal leukoencephalopathy in remission.
Disease activity return after natalizumab cessation in multiple sclerosis.
Is it necessary to perform connective tissue disorders laboratory tests when a patient experiences the first demyelinating attack?
New evidence for teriflunomide in multiple sclerosis.
Fingolimod: A Review of Its Use in Relapsing-Remitting Multiple Sclerosis.
Evaluation of the circulating CD34(+), CD309(+), and endothelial progenitor cells in patients with first attack of optic neuritis.
Chronic inflammatory demyelinating polyradiculoneuropathy with cholesterol deposits in a dog.
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis.
Nerve ultrasound score in distinguishing chronic from acute inflammatory demyelinating polyneuropathy.
Diaphragm Breathing Movement Measurement using Ultrasound and Radiographic Imaging: A Concurrent Validity.
[Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? Comments.]
Pages
« first
‹ previous
…
697
698
699
700
701
702
703
704
705
…
next ›
last »